Our research team has shown that corilagin exerts an anti-inflammatory effect in sepsis through downregulation of expression of TLR4, MyD88, TRIF, and TRAF6 in the TLR4 signaling pathway (31). The gene discussed is TLR4; the disease is Sepsis.